Tag: Illumina
Global Clinical Oncology Next Generation Sequencing Market to Eyewitness Massive Growth by 2028 |
The Global Clinical Oncology Next Generation Sequencing Market is expected to grow at a CAGR of 13.90% in the forecast period of 2020 to 2027.
Global Lung Cancer Diagnostics Market Major Growth Trends with Upcoming Forecasts by 2028 | GE, Illumina, Abbott, QIAGEN, Quest Diagnostics, Roche
The Global Lung Cancer Diagnostics Market is expected to growing at a CAGR of 7.30% in the forecast period of 2020 to 2027.
Global Non-Invasive Prenatal Testing Market 2021: Company Profiles, Trends, Industry Growth, Segments, Landscape and Demand by Forecast to 2028
The Global Non-Invasive Prenatal Testing Market is expected to USD 11.26 billion by 2027 growing at a CAGR of 15.57% in the forecast period of 2020 to 2027.
Global Biomarker Translation Services Market: Global Analytical Overview, Key Players, Regional Demand, Trends and Forecast To 2028
The Global Biomarker Translation Services Market is expected to USD 3.03 Billion by 2027 growing at a CAGR of 10.50% in the forecast period of 2020 to 2027.
Global Microarray Instruments and Reagents Market 2021: Upcoming Trends, Demand, Regional Analysis and Forecast To 2028
The Global Microarray Instruments and Reagents Market is expected to register a substantial CAGR in the forecast period of 2019-2026.
Middle East and Africa Cancer Spit Test Device Market by Top Manufacturers, Product Types, Applications and Forecast to 2028
The Middle East and Africa Cancer Spit Test Device Market is growing with a CAGR of 7.8% in the forecast period of 2021 to 2028 and is expected to reach USD 34.95 Million by 2028 from USD 19.93 Million in 2020.
Europe Cancer Spit Test Device Market: An Insight on the Important Factors and Trends Influencing the Market | Foreseen Till 2028
The Europe Cancer Spit Test Device Market is growing with a CAGR of 9.3% in the forecast period of 2021 to 2028 and is expected to reach USD 224.29 Million by 2028 from USD 115.22 Million in 2020.
Comprehensive study of Asia-Pacific Cancer Spit Test Device Market: Factors affecting growth & Future Trends | Forecast to 2028
The Asia-Pacific Cancer Spit Test Device Market is growing with a CAGR of 10.5% in the forecast period of 2021 to 2028 and is expected to reach USD 209.46 Million by 2028 from USD 98.48 Million in 2020.
2021-2028 North America Cancer Spit Test Device Market Trending Technologies, Remarkable Developments and Key Players like BD, Abbott, Roche
The North America Cancer Spit Test Device Market is growing with a CAGR of 10.0% in the forecast period of 2021 to 2028 and is expected to reach USD 473.28 million by 2028 from USD 230.06 million in 2020.
